Annovis Bio
ANVS
ANVS
30 hedge funds and large institutions have $10.6M invested in Annovis Bio in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
42% less capital invested
Capital invested by funds: $18.3M → $10.6M (-$7.74M)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.85M | |
| 2 | +$61.7K | |
| 3 | +$41.7K | |
| 4 |
FIA
FNY Investment Advisers
New York
|
+$10K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.17K |
Top Sellers
| 1 | -$3.51M | |
| 2 | -$876K | |
| 3 | -$145K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$25.3K |
| 5 |
CAS
Coppell Advisory Solutions
Coppell,
Texas
|
-$15.8K |